These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8896135)

  • 1. Explained variation in survival analysis.
    Schemper M; Stare J
    Stat Med; 1996 Oct; 15(19):1999-2012. PubMed ID: 8896135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Explained variation for logistic regression.
    Mittlböck M; Schemper M
    Stat Med; 1996 Oct; 15(19):1987-97. PubMed ID: 8896134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Explained randomness in proportional hazards models.
    O'Quigley J; Xu R; Stare J
    Stat Med; 2005 Feb; 24(3):479-89. PubMed ID: 15532086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression analysis of interval-censored survival data with covariates using log-linear models.
    Kim DK
    Biometrics; 1997 Dec; 53(4):1274-83. PubMed ID: 9423249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling survival in acute severe illness: Cox versus accelerated failure time models.
    Moran JL; Bersten AD; Solomon PJ; Edibam C; Hunt T;
    J Eval Clin Pract; 2008 Feb; 14(1):83-93. PubMed ID: 18211649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partially linear censored quantile regression.
    Neocleous T; Portnoy S
    Lifetime Data Anal; 2009 Sep; 15(3):357-78. PubMed ID: 19418223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating survival curves with left-truncated and interval-censored data under monotone hazards.
    Pan W; Chappell R
    Biometrics; 1998 Sep; 54(3):1053-60. PubMed ID: 9750251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proportional odds model for multivariate interval-censored failure time data.
    Chen MH; Tong X; Sun J
    Stat Med; 2007 Dec; 26(28):5147-61. PubMed ID: 17476643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An index approach for the Cox model with left censored covariates.
    D'Angelo G; Weissfeld L;
    Stat Med; 2008 Sep; 27(22):4502-14. PubMed ID: 18407573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A joint model for survival and longitudinal data measured with error.
    Wulfsohn MS; Tsiatis AA
    Biometrics; 1997 Mar; 53(1):330-9. PubMed ID: 9147598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.
    Royston P; Parmar MK
    Stat Med; 2002 Aug; 21(15):2175-97. PubMed ID: 12210632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generating survival times to simulate Cox proportional hazards models.
    Bender R; Augustin T; Blettner M
    Stat Med; 2005 Jun; 24(11):1713-23. PubMed ID: 15724232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cure rate model with interval censored data.
    Kim YJ; Jhun M
    Stat Med; 2008 Jan; 27(1):3-14. PubMed ID: 17516589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using SAS to calculate the Kent and O'Quigley measure of dependence for Cox proportional hazards regression model.
    Heinzl H
    Comput Methods Programs Biomed; 2000 Aug; 63(1):71-6. PubMed ID: 10927156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model.
    Goggins WB; Finkelstein DM; Schoenfeld DA; Zaslavsky AM
    Biometrics; 1998 Dec; 54(4):1498-507. PubMed ID: 9883548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the proportional hazards assumption in medical survival studies--application to a population-based study of acute myeloid leukaemia.
    Bourdais-Mannone C; Quantin C; Abrahamowicz M; Mannone L; Brunet-Lecomte P; Aho LS; Solary E; Maynadié M; Carli PM
    J Epidemiol Biostat; 1999; 4(2):83-92. PubMed ID: 10619055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management.
    Rautou PE; Moucari R; Escolano S; Cazals-Hatem D; Denié C; Chagneau-Derrode C; Charpignon C; Lédinghen Vd; Grenouillet-Delacre M; Habersetzer F; Nousbaum JB; Denninger MH; Valla DC; Plessier A
    Am J Gastroenterol; 2009 May; 104(5):1140-6. PubMed ID: 19337247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating survival model performance: a graphical approach.
    Mandel M; Galai N; Simchen E
    Stat Med; 2005 Jun; 24(12):1933-45. PubMed ID: 15806618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing proportional hazards and accelerated failure time models for survival analysis.
    Orbe J; Ferreira E; Núñez-Antón V
    Stat Med; 2002 Nov; 21(22):3493-510. PubMed ID: 12407686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.